Treatment of renal side effects: in patients identified as potentially having developed anti-VEGF therapy-induced renal side effects such as proteinuria, hypertension, or worsening creatinine, no proven therapies can directly facilitate these changes. This evidence concerns the gene VEGFA and hypertensive disorder.